Repositioning of Quinazolinedione-Based Compounds on Soluble Epoxide Hydrolase (sEH) through 3D Structure-Based Pharmacophore Model-Driven Investigation
The development of new bioactive compounds represents one of the main purposes of the drug discovery process. Various tools can be employed to identify new drug candidates against pharmacologically relevant biological targets, and the search for new approaches and methodologies often represents a critical issue. In this context, in silico drug repositioning procedures are required even more in order to re-evaluate compounds that already showed poor biological results against a specific biological target. 3D structure-based pharmacophoric models, usually built for specific targets to accelerate the identification of new promising compounds, can be employed for drug repositioning campaigns as well. In this work, an in-house library of 190 synthesized compounds was re-evaluated using a 3D structure-based pharmacophoric model developed on soluble epoxide hydrolase (sEH). Among the analyzed compounds, a small set of quinazolinedione-based molecules, originally selected from a virtual combinatorial library and showing poor results when preliminarily investigated against heat shock protein 90 (Hsp90), was successfully repositioned against sEH, accounting the related built 3D structure-based pharmacophoric model. The promising results here obtained highlight the reliability of this computational workflow for accelerating the drug discovery/repositioning processes.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:27 |
|---|---|
| Enthalten in: |
Molecules (Basel, Switzerland) - 27(2022), 12 vom: 16. Juni |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Gazzillo, Erica [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 27.06.2022 Date Revised 16.07.2022 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.3390/molecules27123866 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM342660799 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM342660799 | ||
| 003 | DE-627 | ||
| 005 | 20231226014632.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/molecules27123866 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1142.xml |
| 035 | |a (DE-627)NLM342660799 | ||
| 035 | |a (NLM)35744994 | ||
| 035 | |a (PII)3866 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Gazzillo, Erica |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Repositioning of Quinazolinedione-Based Compounds on Soluble Epoxide Hydrolase (sEH) through 3D Structure-Based Pharmacophore Model-Driven Investigation |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 27.06.2022 | ||
| 500 | |a Date Revised 16.07.2022 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a The development of new bioactive compounds represents one of the main purposes of the drug discovery process. Various tools can be employed to identify new drug candidates against pharmacologically relevant biological targets, and the search for new approaches and methodologies often represents a critical issue. In this context, in silico drug repositioning procedures are required even more in order to re-evaluate compounds that already showed poor biological results against a specific biological target. 3D structure-based pharmacophoric models, usually built for specific targets to accelerate the identification of new promising compounds, can be employed for drug repositioning campaigns as well. In this work, an in-house library of 190 synthesized compounds was re-evaluated using a 3D structure-based pharmacophoric model developed on soluble epoxide hydrolase (sEH). Among the analyzed compounds, a small set of quinazolinedione-based molecules, originally selected from a virtual combinatorial library and showing poor results when preliminarily investigated against heat shock protein 90 (Hsp90), was successfully repositioned against sEH, accounting the related built 3D structure-based pharmacophoric model. The promising results here obtained highlight the reliability of this computational workflow for accelerating the drug discovery/repositioning processes | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a anti-inflammatory agents | |
| 650 | 4 | |a chemical synthesis | |
| 650 | 4 | |a computational techniques | |
| 650 | 4 | |a drug discovery | |
| 650 | 4 | |a drug repositioning | |
| 650 | 4 | |a soluble epoxide hydrolase | |
| 650 | 7 | |a Enzyme Inhibitors |2 NLM | |
| 650 | 7 | |a Quinazolinones |2 NLM | |
| 650 | 7 | |a Receptors, Drug |2 NLM | |
| 650 | 7 | |a Epoxide Hydrolases |2 NLM | |
| 650 | 7 | |a EC 3.3.2.- |2 NLM | |
| 700 | 1 | |a Terracciano, Stefania |e verfasserin |4 aut | |
| 700 | 1 | |a Ruggiero, Dafne |e verfasserin |4 aut | |
| 700 | 1 | |a Potenza, Marianna |e verfasserin |4 aut | |
| 700 | 1 | |a Chini, Maria Giovanna |e verfasserin |4 aut | |
| 700 | 1 | |a Lauro, Gianluigi |e verfasserin |4 aut | |
| 700 | 1 | |a Fischer, Katrin |e verfasserin |4 aut | |
| 700 | 1 | |a Hofstetter, Robert Klaus |e verfasserin |4 aut | |
| 700 | 1 | |a Giordano, Assunta |e verfasserin |4 aut | |
| 700 | 1 | |a Werz, Oliver |e verfasserin |4 aut | |
| 700 | 1 | |a Bruno, Ines |e verfasserin |4 aut | |
| 700 | 1 | |a Bifulco, Giuseppe |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Molecules (Basel, Switzerland) |d 2004 |g 27(2022), 12 vom: 16. Juni |w (DE-627)NLM172073448 |x 1420-3049 |7 nnns |
| 773 | 1 | 8 | |g volume:27 |g year:2022 |g number:12 |g day:16 |g month:06 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3390/molecules27123866 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 27 |j 2022 |e 12 |b 16 |c 06 | ||